# A Phase I Study to Evaluate LIFE-001

> **NCT06904807** · PHASE1 · RECRUITING · sponsor: **LifeMine Therapeutics** · enrollment: 150 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LIFE-001
- **DRUG:** Placebo
- **DRUG:** LIFE-001 MAD
- **DRUG:** Placebo MAD

## Key facts

- **NCT ID:** NCT06904807
- **Lead sponsor:** LifeMine Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-07
- **Primary completion:** 2026-11-13
- **Final completion:** 2026-11-13
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06904807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06904807, "A Phase I Study to Evaluate LIFE-001". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06904807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*